Schedule of Reconciliations of Income Tax Expenses (Details) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|---|
Aug. 31, 2026 |
Aug. 31, 2025 |
Aug. 31, 2026 |
Aug. 31, 2025 |
Feb. 28, 2026 |
|
| Income Tax Disclosure [Abstract] | |||||
| Loss before income tax expenses | $ (6,989,552) | $ (7,041,333) | |||
| Income tax credit computed at various statutory income tax rate (15% to 25%) | (994,152) | (440,899) | |||
| Tax incentive – R&D Credit | (69,940) | ||||
| Income not subject to tax in China | (19,847) | (38,590) | |||
| Change in fair value of derivative liabilities | 248,686 | ||||
| Non-deductible expenses | 715,313 | 549,429 | |||
| Total provision for (benefit from) income tax expense | |||||
| X | ||||||||||
- Definition Income tax credit computed at various statutory income tax rate. No definition available.
|
| X | ||||||||||
- Definition Income not subject to tax. No definition available.
|
| X | ||||||||||
- Definition Loss before income tax expenses. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|